Representatives from various biotech and pharmaceutical companies around the world discuss early stage therapies currently under development. Featuring Dr. Friedrich Metzger, PhD, Head of Discover in Rare Diseases at Roche; Dr. Takako Moriguchi, PhD, Senior Scientist at Genzyme; and Michael French, Chief Executive Officer at Marina Biotech.
Mike Adleberg, Dr. Bruce Quinn, MD, PhD, and Dave Zook of Faegre-BD Consulting discuss reimbursement and insurance issues that many people living with DM regularly face.
Dr. Laurence Mignon, PhD, Director of Clinical Development at Isis Pharmaceuticals, gives an update on the status of the DMPKrx Phase I/II trial.
Betsy Furler of BridgingApps discusses apps that can be used to improve daily living for those with DM.
Dr. Sharon Hesterlee, PhD, Chief Science Officer at MDF, discusses the Foundation's multi-year vision to accelerate DM research.